89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
7.94
-0.05 (-0.63%)
Dec 24, 2024, 1:00 PM EST - Market closed
89bio Market Cap
89bio has a market cap or net worth of $933.60 million as of December 24, 2024. Its market cap has increased by 4.23% in one year.
Market Cap
933.60M
Enterprise Value
547.40M
1-Year Change
4.23%
Ranking
Category
Stock Price
$7.94
Market Cap Chart
Since November 12, 2019, 89bio's market cap has increased from $256.62M to $933.60M, an increase of 263.81%. That is a compound annual growth rate of 28.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 933.60M | -10.33% |
| Dec 29, 2023 | 1.04B | 75.74% |
| Dec 30, 2022 | 592.42M | 123.48% |
| Dec 31, 2021 | 265.09M | -45.28% |
| Dec 31, 2020 | 484.45M | 33.64% |
| Dec 31, 2019 | 362.51M | 41.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 956.06M |
| Adaptive Biotechnologies | 943.03M |
| Replimune Group | 941.00M |
| The Pennant Group | 940.46M |
| Liquidia | 939.47M |
| Poseida Therapeutics | 921.06M |
| Nuvation Bio | 902.00M |
| LENZ Therapeutics | 897.35M |